Natriuretic Peptides as Inclusion Criteria in Clinical Trials is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 0.665. It has been cited 83 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.665
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Medtronic
National Institutes of Health
Novartis
MyoKardia
National Heart, Lung, and Blood Institute
Bayer Fund
Boehringer Ingelheim
U.S. Department of Defense
U.S. Food and Drug Administration
Amgen
AstraZeneca
Cytokinetics
GlaxoSmithKline
Abbott Laboratories
Arrien Pharmaceuticals
Gilead Sciences
AbbVie
American Heart Association
Janssen Pharmaceuticals
Merck
Roche
Singulex
U.S. Department of Veterans Affairs
Boston Scientific Corporation
Bristol-Myers Squibb
National Center for Advancing Translational Sciences
Sphingotec GmbH
FWCI
8.67
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords